pentoxifylline has been researched along with Acute Lymphoid Leukemia in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a xanthine that possesses antitumor properties and that can induce higher apoptosis in the leukemic cells of pediatric patients with acute lymphoblastic leukemia (ALL) during treatment with prednisone." | 2.87 | Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia. ( Aguilar-Lemarroy, A; Bravo-Cuellar, A; Gonzalez-Ramella, O; Hernández-Flores, G; Jave-Suárez, LF; Meza-Arroyo, J; Ortiz-Lazareno, P; Padilla-Corona, M; Sanchez-Zubieta, F, 2018) |
| "Pentoxifylline (PTX) has been shown to increase chemotherapy-induced apoptosis." | 2.82 | Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia. ( Bravo-Cuellar, A; Gallegos-Castorena, S; Gonzalez-Ramella, O; Hernández-Flores, G; Jave-Suárez, LF; Jiménez-López, X; Lerma-Díaz, JM; Medina-Barajas, F; Meza-Arroyo, J; Ortiz-Lazareno, PC; Sánchez-Zubieta, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meza-Arroyo, J | 2 |
| Bravo-Cuellar, A | 3 |
| Jave-Suárez, LF | 2 |
| Hernández-Flores, G | 3 |
| Ortiz-Lazareno, P | 1 |
| Aguilar-Lemarroy, A | 1 |
| Padilla-Corona, M | 1 |
| Sanchez-Zubieta, F | 2 |
| Gonzalez-Ramella, O | 2 |
| Ortiz-Lazareno, PC | 1 |
| Jiménez-López, X | 1 |
| Gallegos-Castorena, S | 1 |
| Medina-Barajas, F | 1 |
| Lerma-Díaz, JM | 2 |
| Aguilar-Luna, JC | 1 |
| Barba-Barajas, M | 1 |
| Orbach-Arbouys, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Enhancing Effect on Tumour Apoptosis With the Combined Use of Pentoxifylline Plus Chemotherapeutical Agents in Pediatrics and AYA Patients With Hodgkin´s Lymphoma[NCT05490953] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-07-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pentoxifylline and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia.
Topics: Adolescent; Apoptosis; Child; Child, Preschool; Female; Gene Expression Regulation, Leukemic; Humans | 2018 |
Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia.
Topics: Adolescent; Anti-Inflammatory Agents; Apoptosis; Child; Child, Preschool; Drug Therapy, Combination; | 2016 |
1 other study available for pentoxifylline and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
[In vitro induction of apoptosis in acute myelogenous and lymphoblastic leukemia cells by adriamycine is increased by pentoxifylline].
Topics: Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; In Vitro Techniques; Le | 2010 |